DTaP/IPV/Hib

The DTaP/IPV/Hib - A combined vaccine, introduced in 2004, that provides immunity against diphtheria, tetanus, pertussis (whooping cough), poliomyelitis, and Hib. In this vaccine (and in the dTaP/IPV vaccine), the polio and pertussis parts have been altered to minimize the risk of adverse effects.

HOW IT IS DONE
The injection is given in three doses to infants at two, three, and four months of age, so that they are protected as soon as possible. (Meningitis C vaccination is given at the same time.) The childhood immunization schedule also includes a preschool booster (see dTaP/IPV), and a further diphtheria, tetanus, and polio booster before leaving school. (See Typical childhood immunization schedule,)

PROTECTION
The vaccine provides a very high level of immunity to diphtheria, tetanus, pertussis, polio, and Hib infections.

POSSIBLE ADVERSE EFFECTS
DTaP/IPV/Hib is less likely to cause reactions than the older vaccines. Any side effects are usually mild and tend to occur within 12–24 hours.They include a slightly raised temperature, irritability and fretfulness, and a small lump, redness, and swelling at the injection site. Severe side effects are very rare. The vaccine should not be given to children who have reacted severely to a preceding dose or to the old DTP vaccine, or to children who could have a severe reaction to neomycin, streptomycin, or polymyxin B (see polymyxins), which may exist in the vaccine in trace amounts.